The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Progesterone Formulations - EP3560500

The patent EP3560500 was granted to Therapeuticsmd on Dec 22, 2021. The application was originally filed on Jun 18, 2013 under application number EP19163006A. The patent is currently recorded with a legal status of "Revoked".

EP3560500

THERAPEUTICSMD
Application Number
EP19163006A
Filing Date
Jun 18, 2013
Status
Revoked
Sep 15, 2023
Publication Date
Dec 22, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

DR SCHONSep 22, 2022DR SCHONADMISSIBLE
RIECKSep 21, 2022FUCHS PATENTANWALTE PARTNERSCHAFT MBBADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONUS2003077297
OPPOSITIONUS2011312927
OPPOSITIONUS2011312928
OPPOSITIONUS2012135074
OPPOSITIONWO2008057363
OPPOSITIONWO2013078422
OPPOSITIONWO2013192248
OPPOSITIONWO9740823
SEARCHUS2003077297
SEARCHUS2004052824
SEARCHUS2010255085
SEARCHUS2011312928
SEARCHUS6294192
SEARCHWO2013078422

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents